JP3580453B2 - Cell activating cosmetic - Google Patents

Cell activating cosmetic Download PDF

Info

Publication number
JP3580453B2
JP3580453B2 JP27370995A JP27370995A JP3580453B2 JP 3580453 B2 JP3580453 B2 JP 3580453B2 JP 27370995 A JP27370995 A JP 27370995A JP 27370995 A JP27370995 A JP 27370995A JP 3580453 B2 JP3580453 B2 JP 3580453B2
Authority
JP
Japan
Prior art keywords
skin
bacteria
cell
cosmetic
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP27370995A
Other languages
Japanese (ja)
Other versions
JPH0987134A (en
Inventor
近藤昇一郎
小尾由美子
岩見潤子
岡部敬一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance KK
Original Assignee
Advance KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance KK filed Critical Advance KK
Priority to JP27370995A priority Critical patent/JP3580453B2/en
Publication of JPH0987134A publication Critical patent/JPH0987134A/en
Application granted granted Critical
Publication of JP3580453B2 publication Critical patent/JP3580453B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【0001】
【産業上の利用分野】
本発明は細胞賦活組成物を含有する保湿性を高め若々しい皮膚を保つ化粧料及び該細胞賦活成分を生産する微生物に関する。
【0002】
【従来の技術】
化粧品に使用されている細胞賦活剤としては単一成分原料(感光素、ビタミン、コラーゲンなど)及び抽出成分原料(プラセンタエキス(特願昭59−190909)、ラクトバチルス・アシドフィルス(特願平3−156033)及びストレプトコッカス・サーモフィルス(特願昭57−81287)からなる乳酸菌エキス、霊芝エキスなど)である。
【0003】
【発明が解決しようとする課題】
本発明は安全性の高い細胞賦活作用を有し、かつ、保湿性が高く、皮膚を滑らかにし、若々しい皮膚を保つ性質の化粧料を提供することである。
【0004】
【課題を解決するための手段】
皮膚には色々な皮膚常在菌が棲息しマイクロフローラを形成している。面白いことに健康な人の肌は一様に嫌気性菌のプロピオニバクテリウム・アクネス菌(Propionibacterium acnes)、好気性菌のスタフィロコッカス・エピデルミデイス菌(Staphylococcus epidermides)がそれぞれ10−10個/cm、10−10個/cmという高密度な棲息を示し、皮膚常在菌の上位優勢菌種を成している。健康な肌に、実験的に外来菌を塗布したとしても外来菌は速やかに排除され元の菌叢が自然と回復するということがしばしば観察される。このことはあたかも常在菌が皮膚の感染防御機構の一端を担っているように見える。健康な皮膚が持つ常在菌叢のこれら生態系が構築されるためには、皮膚から供給される優勢常在菌の生産に必要な栄養因子と常在菌が分泌する抗菌様物質などの存在が考えられている。そこで本発明は、まず健康な人の正常皮膚に存在する細菌を採取し、分離培地プレート上で単コロニーを得、その単離皮膚常在菌純粋液培養を行い、その培養菌体及び培養液中にヒト線維芽細胞増殖作用物質があるかの否かの検索を試みた。その結果、プロピオニバクテリウムに属する菌の培養液中に細胞増殖作用を示す成分があること、さらにこれを含有する化粧料として有用であることを見いだし、本発明を完成するに至った。即ち、本発明はプロピオニバクテリウム・アクネスに属し、線維芽細胞に対して細胞賦活作用を示す成分を産生する菌を培養して得られる培養液あるいはその該菌体に由来する物質で線維芽細胞の増殖能を高める成分を含有する化粧料並びに微生物を提供するものである。
【0005】
本発明に用いられる培養液を生産する菌株はプロピオニバクテリウム・アクネスに属し、線維芽細胞に対して特異的に増殖作用を示す成分を生産する菌としては、例えばAD30002株(以下本菌株と言う)が挙げられる。
本菌株の菌学的性質は以下の通りである。
(a)菌の性状:桿菌
(b)運動性:無
(c)胞子形成:観察されず
(d)グラム染色性:陽性
(e)ゼラチン:液化能あり
(f)インドール生成:あり
(g)硝酸還元反応:陽性
(h)カタラーゼ反応:陽性
(i)リパーゼ活性:あり
(j)ガス生成:なし
(k)ウレアーゼ反応:陽性
(l)ヒアルロニダーゼ反応:陰性
(m)生育範囲:pH5−9,温度20−40℃(最適生育温度32−40℃)(n)酸素要求性:偏性嫌気性。但し菌数の多い場合,酸素耐性が認められる。
(o)嫌気条件下での酸の産生能:マルトース(−)
(p)エスクリン加水分解:なし
以上の性質をもとにBergey’s manual of Determinative Bacteriology,第8版,(1974年)の記載から、本菌株をプロピオニバクテリウム・アクネスAD30002と命名し、工業技術院生命工学工業技術研究所に寄託した。(受託番号 FERM P−15186)
【0006】
本発明に用いる線維芽細胞に対して特異的に賦活作用を示す成分は、上記菌株を栄養源含有培地に接種し嫌気的に培養すれば培養中に生産される。かかる菌株としては、上記AD30002株はもとより、人工変異株あるいは自然変異株であっても上記成分を生産する能力を有するものであれば、全て本発明に使用することができる。
【0007】
【実施例】
次に実施例を挙げて本発明を更に具体的に説明するが、本発明は、これにより限定するものではない。
実施例1
プロピオニバクテリウム・アクネスAD30002株を下記のGAM液体培地に接種し、37℃で嫌気培養を行い、得られた培養液を15,000rpmの連続遠心分離に付し、菌体上清を0.22ミクロンのフィルターを用いて無菌ろ過し培養上清液を得た。一方、菌体は生理的食塩水でよく洗い洗浄菌体を得た。この洗浄菌体を80%アセトンで抽出し、次いで酢酸エチルで抽出したものをエバポレーターで蒸発乾固し菌体抽出物を得た。
GAM液体培地の組成(1リットル当たり)
ペプトン 10.0g
ダイズペプトン 3.0g
プロテオーゼペプトン 10.0g
消化血清末 13.5g
酵母エキス 5.0g
肉エキス 2.2g
肝臓エキス末 1.2g
ブドウ糖 3.0g
リン酸二水素カリウム 2.5g
塩化ナトリウム 3.0g
溶性デンプン 5.0g
L−システイン塩酸塩 0.3g
チオグリコール酸 0.3g
pH 7.3±0.1
【0008】
実験例 1(細胞賦活作用)
ヒト繊維芽細胞(NBIRGB、理化学研究所より購入)を予め、10%FCS加RITC−80培地にて5%CO,37℃の条件下で4日間培養した。その培養細胞は、その後、PBS緩衝液で2度洗浄し、0.25%トリプシン処理にて細胞をはがし、同培地で 8 × 10細胞/ml細胞浮遊液に調製した。これを96穴マイクロプレートに0.1mlずつ分注し同培養条件下で前培養(4時間)を行った。サンプルは同培地(無血清)で1.0%,0.3%,0.03%(濃度は実施例1の容量%、但し菌体抽出液は培養液1ml相当量の容量%)に希釈したものを各々0.011mlずつ96穴に添加して培養した。判定はニュ−トラルレッドで生細胞を染色(37℃,1時間)し、0.1M NaHPO・2HO:エタノール(1:1)で溶出後、分光光度計を用いて波長540nmでの吸光度を測定し、細胞増殖能を算出した。その結果を表1に示した。
【表1】

Figure 0003580453
上記のごとく、培養上清液(P<0.05)及び菌体抽出液(P<0.01)には明らかに線維芽細胞に対して有意に増殖効果が認められた。一方、皮膚常在菌であるスタフィロコッカス・エピデルミデス菌や皮膚有害菌であるスタフィロコッカス・アウレウス菌及びマイクロコッカス菌属には増殖効果が認められず、本菌株の細胞賦活作用の有用性が示された。
【0009】
安全性
実施例1で得られた菌体培養液をソニケーション処理(氷冷で20分間)し、その上清液を0.22ミクロンのフィルターを用いて無菌ろ過したものにグリセリンを加えて試験液とした。これを成人男子(n=1)前腕曲内側皮膚に貼付し、24時間後の皮膚刺激性について観察を行い表2に示す結果を得た。
【表2】
Figure 0003580453
上記のように、安全性になんら問題はない。
【0010】
実施例2 (ローション)
上記実施例1で得られた培養菌体(10細胞/ml相当量)を80%アセトンで抽出後、アセトンを除去する。この溶液を0.22ミクロンのフィルターでろ過し精製水で10倍に希釈したもの94.9gにグリセリン5.0g、パラオキシ安息香酸0.1gを攪拌添加してローションを得た。(配合量は重量%)
【0011】
実施例3 (クリーム)
上記実施例2で得られた培養菌体抽出液5g、グリセリン5g、ポリエチレングリコール(400) 2g及び精製水70gを70℃加熱混合溶解した中へ、予めセタノール4g,スクワラン5g,ステアリン酸1g,ミツロウ1g,ワセリン2g、グリセリンモノステアレート2g、パラオキシ安息香酸エチルエステル0.1gと少量の香料を加熱混合溶解させたものを攪拌混合して、ホモジナイザーで乳化し室温まで冷却してクリームを得た。(配合量は重量%)
【0012】
【発明の効果】
本発明のプロピオニバクテリウム・アクネスの培養上清あるいは菌体抽出液を含む化粧料は線維芽細胞の増殖効果を有する。従ってこれを含有する化粧料は皮膚の保湿性を高め、皮膚を滑らかにし、若々しい皮膚を保つ効果が期待され、かつ安全性についても問題はない。[0001]
[Industrial application fields]
The present invention relates to a cosmetic containing a cell activation composition to enhance moisture retention and maintain a youthful skin, and a microorganism that produces the cell activation component.
[0002]
[Prior art]
Cell activators used in cosmetics include single-component raw materials (photosensitive elements, vitamins, collagen, etc.) and extractive raw materials (placenta extract (Japanese Patent Application No. 59-190909)), Lactobacillus acidophilus (Japanese Patent Application No. 3- Lactic acid bacteria extract, reishi extract and the like) consisting of Streptococcus thermophilus (Japanese Patent Application No. 57-81287).
[0003]
[Problems to be solved by the invention]
It is an object of the present invention to provide a cosmetic having a highly safe cell activation effect, high moisturizing property, smooth skin and keeping youthful skin.
[0004]
[Means for Solving the Problems]
Various skin resident bacteria inhabit the skin and form microflora. Interestingly, the healthy skin is uniformly composed of 10 4 -10 5 anaerobic bacteria, Propionibacterium acnes, and aerobic bacteria, Staphylococcus epidermidides. / cm 2, 10 3 -10 4 cells / cm 2 showed a high density habitat that forms a upper predominant species of indigenous dermal bacteria. Even when exogenous bacteria are experimentally applied to healthy skin, it is often observed that the exogenous bacteria are quickly eliminated and the original flora naturally recovers. This seems as if resident bacteria play a part in the defense mechanism of skin infection. In order for these ecosystems of the normal flora of healthy skin to be built, the presence of nutritional factors necessary for the production of dominant normal bacteria supplied from the skin and antimicrobial-like substances secreted by the normal bacteria Is considered. Therefore, the present invention first collects bacteria present in normal healthy human skin, obtains a single colony on a separation medium plate, conducts pure liquid culture of the isolated skin resident bacteria, and culture cells and culture solution thereof. Attempts were made to determine whether there are any human fibroblast proliferating agents. As a result, it has been found that a component exhibiting cell proliferation activity is present in the culture solution of bacteria belonging to Propionibacterium, and that the composition is useful as a cosmetic containing the component, and the present invention has been completed. That is, the present invention belongs to Propionibacterium acnes, and a fibroblast is obtained from a culture solution obtained by culturing a bacterium that produces a component that exhibits a cell activation effect on fibroblasts or a substance derived from the microbial cell. The present invention provides a cosmetic and a microorganism containing a component that enhances cell growth ability.
[0005]
The strain that produces the culture solution used in the present invention belongs to Propionibacterium acnes, and as a bacterium that produces a component that specifically exhibits a proliferative action on fibroblasts, for example, the AD30002 strain (hereinafter referred to as this strain) Say).
The mycological properties of this strain are as follows.
(A) Fungus properties: Neisseria gonorrhoeae (b) Motility: No (c) Spore formation: Not observed (d) Gram stainability: Positive (e) Gelatin: Capable of liquefaction (f) Indole formation: Yes (g) Nitrate reduction reaction: positive (h) catalase reaction: positive (i) lipase activity: yes (j) gas generation: no (k) urease reaction: positive (l) hyaluronidase reaction: negative (m) growth range: pH 5-9, Temperature 20-40 ° C. (optimum growth temperature 32-40 ° C.) (n) Oxygen requirement: obligate anaerobic. However, oxygen tolerance is observed when the number of bacteria is large.
(O) Acid production ability under anaerobic conditions: maltose (-)
(P) Esculin hydrolysis: Based on the above properties, the strain was named Propionibacterium acnes AD30002 from the description of Bergey's manual of Determinative Bacteriology, 8th edition, (1974). Deposited at the Institute of Biotechnology, Institute of Technology. (Accession number FERM P-15186)
[0006]
Ingredients that specifically activate the fibroblasts used in the present invention are produced during culture if the strain is inoculated into a nutrient-containing medium and cultured anaerobically. Such strains can be used in the present invention as long as they have the ability to produce the above components, including the above-mentioned AD30002 strain, as well as artificial mutants or natural mutants.
[0007]
【Example】
EXAMPLES Next, the present invention will be described more specifically with reference to examples, but the present invention is not limited thereto.
Example 1
Propionibacterium acnes AD30002 strain is inoculated into the following GAM liquid medium, anaerobic culture is performed at 37 ° C., the obtained culture solution is subjected to continuous centrifugation at 15,000 rpm, and the cell supernatant is treated with 0. Aseptic filtration was performed using a 22 micron filter to obtain a culture supernatant. On the other hand, the cells were washed thoroughly with physiological saline to obtain washed cells. The washed cells were extracted with 80% acetone and then extracted with ethyl acetate, and evaporated to dryness with an evaporator to obtain a cell extract.
Composition of GAM liquid medium (per liter)
Peptone 10.0g
Soybean peptone 3.0g
Proteose peptone 10.0g
Digested serum powder 13.5g
Yeast extract 5.0g
Meat extract 2.2g
Liver extract powder 1.2g
Glucose 3.0g
Potassium dihydrogen phosphate 2.5g
Sodium chloride 3.0g
Soluble starch 5.0g
L-cysteine hydrochloride 0.3g
Thioglycolic acid 0.3g
pH 7.3 ± 0.1
[0008]
Experimental example 1 (cell activation)
Human fibroblasts (NBIRGB, purchased from RIKEN) were cultured beforehand in a RITC-80 medium supplemented with 10% FCS for 4 days under conditions of 5% CO 2 and 37 ° C. The cultured cells were then washed twice with PBS buffer, peeled off by 0.25% trypsin treatment, and prepared to 8 × 10 3 cells / ml cell suspension with the same medium. This was dispensed in 0.1 ml portions into a 96-well microplate and pre-cultured (4 hours) under the same culture conditions. Samples were diluted to 1.0%, 0.3%, 0.03% in the same medium (serum-free) (concentrations were volume% of Example 1, but the cell extract was volume% corresponding to 1 ml of culture solution) 0.011 ml of each was added to 96 wells and cultured. Judgment was performed by staining live cells with neutral red (37 ° C., 1 hour), eluting with 0.1 M NaH 2 PO 4 .2H 2 O: ethanol (1: 1), and then using a spectrophotometer at a wavelength of 540 nm. Absorbance was measured and cell proliferation ability was calculated. The results are shown in Table 1.
[Table 1]
Figure 0003580453
As described above, the culture supernatant (P <0.05) and the bacterial cell extract (P <0.01) clearly showed a significant proliferation effect on fibroblasts. On the other hand, Staphylococcus epidermides bacteria that are skin resident bacteria and Staphylococcus aureus bacteria and Micrococcus genus bacteria that are harmful to skin have no growth effect, and the cell activation effect of this strain is not useful. Indicated.
[0009]
Safety The microbial cell culture solution obtained in Example 1 was subjected to sonication treatment (ice-cooling for 20 minutes), and the supernatant was sterilized using a 0.22 micron filter to obtain glycerin. To obtain a test solution. This was affixed to the inner skin of an adult male (n = 1) forearm curve, and the skin irritation after 24 hours was observed to obtain the results shown in Table 2.
[Table 2]
Figure 0003580453
As mentioned above, there is no problem with safety.
[0010]
Example 2 (lotion)
After extraction the resulting cultured cells in Example 1 (10 9 cells / ml equivalent) in 80% acetone to remove the acetone. This solution was filtered through a 0.22 micron filter and diluted 10-fold with purified water. To 94.9 g, 5.0 g of glycerin and 0.1 g of paraoxybenzoic acid were added with stirring to obtain a lotion. (Mixed amount is% by weight)
[0011]
Example 3 (cream)
5 g of cultured cell extract obtained in Example 2 above, 5 g of glycerin, 2 g of polyethylene glycol (400) and 70 g of purified water were mixed by heating at 70 ° C. and dissolved in advance, 4 g of cetanol, 5 g of squalane, 1 g of stearic acid, beeswax 1 g, petrolatum 2 g, glycerin monostearate 2 g, paraoxybenzoic acid ethyl ester 0.1 g and a small amount of fragrance were mixed by heating, mixed and stirred, emulsified with a homogenizer, and cooled to room temperature to obtain a cream. (Mixed amount is% by weight)
[0012]
【The invention's effect】
The cosmetic comprising the culture supernatant or cell extract of Propionibacterium acnes of the present invention has a fibroblast proliferation effect. Therefore, the cosmetics containing this are expected to have an effect of improving the moisture retention of the skin, smoothing the skin and keeping the youthful skin, and there is no problem with respect to safety.

Claims (1)

プロピオニバクテリウム・アクネス (Propionibacterium acnes) AD30002(生工研菌寄 , 第FERM P−15186号)に属する菌の抽出物又はそれらの培養液から得られた抽出物の一方又は両方を含む肌用の細胞賦活性化粧料。 For skin containing one or both of extracts of fungi belonging to Propionibacterium acnes AD30002 (Seiko Kenkyusho , No. FERM P-15186) or extracts obtained from their cultures of cell stimulatory cosmetic.
JP27370995A 1995-09-28 1995-09-28 Cell activating cosmetic Expired - Fee Related JP3580453B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27370995A JP3580453B2 (en) 1995-09-28 1995-09-28 Cell activating cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27370995A JP3580453B2 (en) 1995-09-28 1995-09-28 Cell activating cosmetic

Publications (2)

Publication Number Publication Date
JPH0987134A JPH0987134A (en) 1997-03-31
JP3580453B2 true JP3580453B2 (en) 2004-10-20

Family

ID=17531469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27370995A Expired - Fee Related JP3580453B2 (en) 1995-09-28 1995-09-28 Cell activating cosmetic

Country Status (1)

Country Link
JP (1) JP3580453B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013060771A3 (en) * 2011-10-25 2014-01-30 Arch Personal Care Products, L.P. Composition containing an extract of a sequential or simultaneous fermentation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000003233A1 (en) * 2020-02-18 2021-08-18 Aileens Pharma S R L BACTERIAL STRAIN AND ITS MEDICAL USES

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013060771A3 (en) * 2011-10-25 2014-01-30 Arch Personal Care Products, L.P. Composition containing an extract of a sequential or simultaneous fermentation

Also Published As

Publication number Publication date
JPH0987134A (en) 1997-03-31

Similar Documents

Publication Publication Date Title
US4710379A (en) Intestinal microflora-improving agent
CA1262442A (en) Anticariogenic or antiperiodontitic agent
JP4731469B2 (en) Composition containing Lactobacillus plantarum strain in combination with tannin, and novel Lactobacillus plantarum strain
US4579733A (en) Hypocholesterolemically and/or hypotriglyceridemically active products
CN113930361B (en) Fermentation medium of lactobacillus paracasei and application thereof
KR20180108504A (en) Fermented product of colostrum and a cosmetic composition using the same
KR101425716B1 (en) Novel Strain of Lactobacillus fermentum spp., Cosmetic Composition Using the same and Preparation Method thereof
JP3400282B2 (en) Lipid metabolism improver and food containing it
KR20000039570A (en) Cosmetics composition containing fermentation broth of lactobacillus
CN111849836A (en) Lactobacillus rhamnosus with oxidation resistance and life prolonging functions and application thereof
EP0524732B1 (en) Composition containing lactic acid bacteria for preventing dental caries
WO2024078561A1 (en) Bifidobacterium animalis strain and use
CN117264839A (en) Application of saliva combined with lactobacillus MB1 in preparation of food and medicine for whitening and relieving gout
JP3580453B2 (en) Cell activating cosmetic
JPS63179829A (en) Antibacterial agent for skin
CN111991428A (en) Probiotic composition with asthma improving effect and preparation method thereof
JP3684205B2 (en) Lactococcus lactis CBT-19, method for producing antibacterial culture broth separation concentrate using the same, and cosmetic composition containing the same
CN113956993B (en) Lactobacillus paracasei with effect of relieving oxidative damage of human keratinocytes
KR100302505B1 (en) Fermented product using lactic acid bacteria and cosmetic composition
EP0396744B1 (en) Lipid peroxide content reducer
JP3579134B2 (en) Cosmetics
CN117384788B (en) Saliva combined lactobacillus SM4 and application thereof in preparation of whitening and cholesterol lowering foods and medicines
JP3384907B2 (en) New bifidobacteria and their use
JPS6270307A (en) Skin cosmetic
JPH0899888A (en) Glutathione peroxidase activator

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040301

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040430

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040618

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040715

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070730

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080730

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090730

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110730

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110730

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 8

LAPS Cancellation because of no payment of annual fees